Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Telotristat Etiprate Shows Benefit in Treating Patients With Carcinoid Syndrome That is Inadequately Controlled by Somatostatin Analog Therapy in the Phase 3 TELESTAR Clinical Trial Kulke, M. H., Hoersch, D., Caplin, M., Anthony, L., Bergsland, E., Oberg, K., Welin, S., Warner, R., Lombard-Bohas, C., Kunz, P., Grande, E., Valle, J. W., Fleming, D., Lapuerta, P., Banks, P., Jackson, S., Wheeler, D., Zambrowicz, B., Sands, A., Pavel, M. LIPPINCOTT WILLIAMS & WILKINS. 2016: 478
View details for Web of Science ID 000370956600058